top_left_nav_bg
top_rht_nav_bg
hdr_img1
spacer
Who's using Liquid Scenarios now?

In 2007, the average venture funds licensing our products had 10 times as much capital under management as their peers, both for US funds and for UK funds.

These VCs also had the most popular, and expensive, fund management, analytic and accounting solutions. Still, they chose Liquid Scenarios Enterprise for their investing partners and their finance teams. Why?

Simply ask the best members of your team to attempt any of the items below with any of your portfolio companies, using any of your very best systems.

mid_btm_bg
 
Typical VC User Case - Part 1

With 4 rounds of funding and 3 classes of warrants , multiple liquidation preferences and some participating preferred outstanding, what exit value will give the series B we hold a payout of $2.36 per share if an exit occurs 340 days in the future?

Completed in 30 seconds with Liquid Scenarios

The last round we participated in was $1.50 per share, if the next round is priced at $2.00, $1.20, $1.4320, or $2.03 per share, what will our overall fund's payout muliple be at each of 38 exit values two years from now, assuming we don't participate in any future rounds? Where does each of these scenarios leave management and other VCs investing in the deal?

For each of the 152 scenarios above (4 Series X pricing possibilities accross 38 exits) , how many of the options and warrants were in the money and by exatcly how much? What was the dilutive effect of those exercises on our fund's preferred, assuming warrants were settled net (cashless exercise) and proceeds from option exercises were added to the original exit values?

Completed in 2 minutes with Liquid Scenarios

mid_btm_bg
 
Typical VC User Case - Part 2

Right click on an existing investor in the analysis above, to open their contact information in Outlook, and import another investor we know intends to participate from our existing Outlook contacts.

Import the portfolio company's list of comparable industry mergers/acquisitions and IPOs, take 70% of those figures, apply a present value discount of 40% and see what kind of impact that has on our outcomes, assuming each of the 4 financing scenarios created previously. Save that case as a separate set of exit scenarios.

Import the portfolio company's projected income statements for the next 5 years and create 15 exit scenarios, 1 that assumes 20X EBITDA, discounted to today, one that assumes, 2.8X revenue and another that assumes 5 times revenue for each of the next 5 years. Also, reduce each of the exit values for 1.5% in legal expenses and 5% in investment banker fees. Save a copy to a secure location on your fund's server that will allow an intern assisting on the deal to open the file, but only to adjust areas your CFO has authorized them to edit, and don't allow them to distribute the file outside of the fund.

Email another copy of the file, with a term sheet for the Series X accessible from within the system to one recipient, but not accessible to another, and view what areas they proposed adjustments to, and the impact of those adjustments on each of the scenarios above.

Export a version of the payout multiples you generated to a hold-out investor that does not quite understand the deal terms and why the proposed financing is actually good for prior investors like them. Also, export a copy of the projected shareholder consents you currently have in the system, showing how voting against the round will not likely impact the outcome, but might of course impact a series of relationships.

Send another copy of the file to your analyst's handheld, so they can update the scenarios with the revised deal terms, throw in a potential convertible bridge note with warrant coverage and have it back to you in the next hour.

Completed in 5 minutes with Liquid Scenarios

mid_btm_bg

Total Minutes To Generate The 1MM+ Outputs Above

7.5

try_btn
 
 
 
 
 
 
 
business_partnerbusiness_partnerbusiness_partnerbusiness_partnerbusiness_partnerbusiness_partner
Privacy Policy - Contact bpCentral
Copyright 2003-2008 bpCentral, Inc. All Rights Reserved Patents Pending